Nicholas Truong

Breaking💥💥 Pfizer announced final results from an analysis of all 2,246 adults enrolled,Phase 2/3 EPIC-HR RCT of PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), it reduced the risk of hospitalization or death for any cause by 89% pfizer.com/news/press-rel…

New data from 3rd shot Moderna (booster, 50 μg) vs Omicron induces substantial increase in neutralization activity, presented today by @WHCOVIDResponse youtube.com/watch?v=4lDuF6…

On #HumanRightsDay our message is clear: HEALTH IS A HUMAN RIGHT To achieve #HealthForAll, the 🌎🌍🌏 needs to build sustainable, peaceful societies based on equality & non-discrimination, equal opportunities & respect for the rights & freedoms of all. bit.ly/3EGfDoA

CDC has expanded recommendations for #COVID19 vaccine booster shots to now include everyone 16 years and older. At this time, only the Pfizer-BioNTech COVID-19 vaccine is authorized and recommended for adolescents aged 16 and 17. Learn more: bit.ly/3mrK4Z5

The receptor binding domain of Omicron, with its 15 mutations, compared with Delta's 2, and the prediction this leads to higher ACE2 binding biorxiv.org/content/10.110…

The latest CDC #FluView continues to show slow, steady increases in flu activity, mostly caused by influenza A(H3N2) viruses. Most of these infections have been in children & young adults aged 5 – 24, a group that commonly drives community flu spread: bit.ly/2AfIS02.

The @WHO has named B.1.1.529 Omicron, a Variant of Concern [O, not Nu)